{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:13:02Z","timestamp":1783660382615,"version":"3.55.0"},"reference-count":177,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>This review synthesizes recent advances in WHO-endorsed NAATs for TB diagnosis and drug resistance detection. We examine the principles, genetic targets, diagnostic performance, implementation settings, and programmatic role of assays across the spectrum of technological complexity, from cartridge-based platforms to line probe assays and sequencing-based technologies. In addition, we highlight emerging molecular tools that show promise for future WHO endorsement and may further strengthen decentralized and near-patient testing. Low- and moderate-complexity assays such as Xpert\u00ae MTB\/RIF, Xpert\u00ae Ultra, and TruenatTM MTB\/MTB Plus have emerged as essential frontline tools for TB diagnosis and rifampicin resistance detection, especially in decentralized settings. LPAs, including GenoType\u00ae MTBDRplus and MTBDRsl, extend resistance profiling to isoniazid, fluoroquinolones, and second-line injectables, and remain valuable in intermediate and central laboratories. More recent developments, including Xpert\u00ae XDR, Deeplex\u00ae Myc-TB, AmPORE-TB\u00ae, and TBseq\u00ae, enable broader resistance detection and, in the case of targeted sequencing assays, comprehensive characterization of multidrug-resistant and extensively drug-resistant TB (MDR\/XDR-TB). Emerging diagnostic innovations\u2014such as CRISPR-based detection systems, streamlined isothermal amplification assays, and portable sequencing technologies\u2014further expand the landscape and may complement existing WHO-endorsed platforms. Importantly, these technologies reduce delays in regimen selection, improve patient outcomes, and provide critical data for surveillance. Nevertheless, performance gaps for rare mutations, limited sensitivity in paucibacillary or extrapulmonary disease, infrastructure requirements, and cost remain barriers to universal adoption. The evolution of TB molecular diagnostics demonstrates a clear shift toward more rapid, accurate, and comprehensive resistance detection. No single assay is universally optimal, yet the combined portfolio, spanning rapid cartridge-based NAATs, LPAs, and next-generation sequencing, forms a complementary framework for improving diagnosis, optimizing treatment, and supporting global TB elimination strategies.<\/jats:p>","DOI":"10.3390\/diagnostics16132133","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:40:09Z","timestamp":1783525209000},"page":"2133","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current Landscape of Molecular Diagnostic Tests and Emerging Tools for Tuberculosis and Drug Resistance"],"prefix":"10.3390","volume":"16","author":[{"given":"Safaa","family":"El Kassimi","sequence":"first","affiliation":[{"name":"Laboratory of Microbiology and Molecular Biology, Faculty of Sciences of Rabat, Mohammed V University, Rabat 10100, Morocco"},{"name":"Prevention & Therapeutics Center, Moroccan Foundation for Advanced Science, Innovation and Research (MAScIR), Mohammed VI Polytechnic University (UM6P), Ben Guerir 43150, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0365-9391","authenticated-orcid":false,"given":"Rkia","family":"Eddabra","sequence":"additional","affiliation":[{"name":"Higher Institute of Nursing Professions and Technical Health, Agadir 80000, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouchra","family":"Belkadi","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Molecular Biology, Faculty of Sciences of Rabat, Mohammed V University, Rabat 10100, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2727-3389","authenticated-orcid":false,"given":"Abdelkarim","family":"Filali-Maltouf","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Molecular Biology, Faculty of Sciences of Rabat, Mohammed V University, Rabat 10100, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5815-3531","authenticated-orcid":false,"given":"Hassan","family":"Ait Benhassou","sequence":"additional","affiliation":[{"name":"Prevention & Therapeutics Center, Moroccan Foundation for Advanced Science, Innovation and Research (MAScIR), Mohammed VI Polytechnic University (UM6P), Ben Guerir 43150, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2024). Global Tuberculosis Report 2024, World Health Organization. Available online: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO\u2019s new End TB strategy","volume":"385","author":"Uplekar","year":"2015","journal-title":"The Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(10)60483-7","article-title":"Tuberculosis control and elimination 2010-50: Cure, care, and social development","volume":"375","author":"Castro","year":"2010","journal-title":"The Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/17476348.2021.1927718","article-title":"Extrapulmonary tuberculosis","volume":"15","author":"Sharma","year":"2021","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_6","first-page":"392","article-title":"The natural history of childhood intra-thoracic tuberculosis: A critical review of literature from the pre-chemotherapy era","volume":"8","author":"Marais","year":"2004","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S1473-3099(06)70578-3","article-title":"Fluorescence versus conventional sputum smear microscopy for tuberculosis: A systematic review","volume":"6","author":"Steingart","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/antibiotics3030317","article-title":"Drug resistance mechanisms in Mycobacterium tuberculosis","volume":"3","author":"Palomino","year":"2014","journal-title":"Antibiotics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"Boehme","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","article-title":"Xpert MTB\/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: A prospective multicentre diagnostic accuracy study","volume":"18","author":"Dorman","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e00812-17","DOI":"10.1128\/mBio.00812-17","article-title":"The New Xpert MTB\/RIF Ultra: Improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing","volume":"8","author":"Chakravorty","year":"2017","journal-title":"mBio"},{"key":"ref_12","unstructured":"World Health Organization (2022). Manual for Selection of Molecular WHO-Recommended Rapid Diagnostic Tests for Detection of Tuberculosis and Drug-Resistant Tuberculosis, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240042575."},{"key":"ref_13","unstructured":"World Health Organization (2023). Research and Development for Tuberculosis: Analysis of TB R&D Pipeline, World Health Organization. Available online: www.who.int\/observatories\/global-observatory-on-health-research-and-development\/analyses-and-syntheses\/tuberculosis\/analysis-of-tb-r-d-pipeline."},{"key":"ref_14","unstructured":"Molbio Diagnostics (2025). Truenat\u00ae Assays, Molbio Diagnostics. Available online: www.molbiodiagnostics.com\/truenat-assays\/."},{"key":"ref_15","unstructured":"World Health Organization (2016). The Use of Loop-Mediated Isothermal Amplification (TB-LAMP) for the Diagnosis of Pulmonary Tuberculosis: Policy Guidance, WHO. Available online: https:\/\/iris.who.int\/handle\/10665\/249154."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1183\/09031936.00089808","article-title":"Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan","volume":"33","author":"Feldmann","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Dookie, N., Khan, A., Padayatchi, N., and Naidoo, K. (2022). Application of next generation sequencing for diagnosis and clinical management of drug-resistant tuberculosis: Updates on recent developments in the field. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.775030"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S1473-3099(24)00263-9","article-title":"Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: A systematic review and meta-analysis","volume":"24","author":"Schwab","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Steingart, K.R., Sohn, H., Schiller, I., Kloda, L.A., Boehme, C.C., Pai, M., and Dendukuri, N. (2013). Xpert\u00ae MTB\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst. Rev., CD009593.","DOI":"10.1002\/14651858.CD009593.pub2"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jinf.2012.02.012","article-title":"Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB\/RIF assay: A meta-analysis","volume":"64","author":"Chang","year":"2012","journal-title":"J. Infect."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/JCM.01463-09","article-title":"Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology","volume":"48","author":"Helb","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Vassall, A., van Kampen, S., Sohn, H., Michael, J.S., John, K.R., den Boon, S., Davis, J.L., Whitelaw, A., Nicol, M.P., and Gler, M.T. (2011). Rapid diagnosis of tuberculosis with the Xpert MTB\/RIF assay in high burden countries: A cost-effectiveness analysis. PLoS Med., 8.","DOI":"10.1371\/journal.pmed.1001120"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5588\/ijtld.14.0262","article-title":"Diagnostic accuracy of the Xpert\u00ae MTB\/RIF assay for extra-pulmonary tuberculosis: A meta-analysis","volume":"19","author":"Penz","year":"2015","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1700918","DOI":"10.1183\/13993003.00918-2017","article-title":"Implementation of Xpert MTB\/RIF in 22 high tuberculosis burden countries: Are we making progress?","volume":"50","author":"Cazabon","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_25","unstructured":"World Health Organization (2017). WHO Meeting Report of a Technical Expert Consultation: Non-Inferiority Analysis of Xpert MTB\/RIF Ultra Compared to Xpert MTB\/RIF, World Health Organization. Available online: www.who.int\/publications\/i\/item\/WHO-HTM-TB-2017.04."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Singh, U.B., Pandey, P., Mehta, G., Bhatnagar, A.K., Mohan, A., Goyal, V., Ahuja, V., Ramachandran, R., Sachdeva, K.S., and Samantaray, J.C. (2016). Genotypic, phenotypic and clinical validation of GeneXpert in extra-pulmonary and pulmonary tuberculosis in India. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149258"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5588\/ijtld.19.0298","article-title":"Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda","volume":"24","author":"Ngabonziza","year":"2020","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e01696-17","DOI":"10.1128\/JCM.01696-17","article-title":"False-Positive Xpert MTB\/RIF Results in Retested Patients with Previous Tuberculosis: Frequency, Profile, and Prospective Clinical Outcomes","volume":"56","author":"Theron","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_29","unstructured":"Foundation for Innovative New Diagnostics (FIND) (2017). 2017 Launch of New TB Test Ultra Backed by WHO Recommendation, FIND. Available online: https:\/\/www.finddx.org\/publications-and-statements\/press-release\/2017-launch-of-new-tb-test-ultra-backed-by-who-recommendation\/."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e00560-18","DOI":"10.1128\/JCM.00560-18","article-title":"Performance of Xpert MTB\/RIF, Xpert Ultra, and Abbott RealTime MTB for diagnosis of pulmonary tuberculosis in a high-HIV-burden setting","volume":"56","author":"Berhanu","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1097\/INF.0000000000001960","article-title":"Accuracy of Xpert MTB\/RIF Ultra for the diagnosis of pulmonary tuberculosis in children","volume":"37","author":"Nicol","year":"2018","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(17)30474-7","article-title":"Diagnostic accuracy of Xpert MTB\/RIF Ultra for tuberculous meningitis in HIV-infected adults: A prospective cohort study","volume":"18","author":"Bahr","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41588-017-0029-0","article-title":"Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis","volume":"50","author":"Coll","year":"2018","journal-title":"Nat. Genet."},{"key":"ref_34","first-page":"CD009593","article-title":"Xpert Ultra versus Xpert MTB\/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis","volume":"2","author":"Zifodya","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e00659-18","DOI":"10.1128\/JCM.00659-18","article-title":"Evaluation of the Xpert MTB\/RIF Ultra assay for direct detection of Mycobacterium tuberculosis complex in smear-negative extrapulmonary samples","volume":"56","author":"Alcaide","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Naidoo, P., Dunbar, R., Caldwell, J., Lombard, C., and Beyers, N. (2017). Has universal screening with Xpert\u00ae MTB\/RIF increased the proportion of multidrug-resistant tuberculosis cases diagnosed in a routine operational setting?. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0172143"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1183\/13993003.00543-2016","article-title":"Development, roll-out and impact of Xpert MTB\/RIF for tuberculosis: What lessons have we learnt and how can we do better?","volume":"48","author":"Albert","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_38","unstructured":"World Health Organization, and Global Laboratory Initiative (2022). Practical Manual of Processing Stool Samples for Diagnosis of Childhood TB, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240042650."},{"key":"ref_39","unstructured":"World Health Organization (2020). WHO Consolidated Guidelines on Tuberculosis. Module 3: Rapid Diagnostics for Tuberculosis Detection, WHO. [3rd ed.]. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240089488."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijmyco.2014.04.003","article-title":"Evaluation of the Indian TrueNAT micro RT-PCR device with GeneXpert for case detection of pulmonary tuberculosis","volume":"3","author":"Nikam","year":"2014","journal-title":"Int. J. Mycobacteriol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ssengooba, W., Katamba, A., Sserubiri, J., Semugenze, D., Nyombi, A., Byaruhanga, R., Turyahabwe, S., and Joloba, M.L. (2024). Performance evaluation of Truenat MTB and Truenat MTB-RIF DX assays in comparison to GeneXpert MTB\/RIF Ultra for the diagnosis of pulmonary tuberculosis in Uganda. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-09063-z"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"17741","DOI":"10.1038\/s41598-022-21025-6","article-title":"In silico evaluation of WHO-endorsed molecular methods to detect drug resistant tuberculosis","volume":"12","author":"Brankin","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_43","unstructured":"Molbio Diagnostics (2025). Truenat\u00ae Brochure, Molbio Diagnostics. Available online: https:\/\/www.molbiodiagnostics.com\/wp-content\/uploads\/2025\/04\/Truenat_Brochure_Soft.pdf."},{"key":"ref_44","first-page":"470","article-title":"Diagnostic evaluation of Tru-Nat MTB\/Rif test in comparison with microscopy for diagnosis of pulmonary tuberculosis at tertiary care hospital of eastern Uttar Pradesh","volume":"16","author":"Ranjan","year":"2024","journal-title":"Iran. J. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Mallya, S.P., Mbelele, P.M., Kisonga, R.M., Mtunga, D.D., Banzi, H.H., Mpiima, S.S., Twinomujuni, M., Bazira, J., and Kassaza, K. (2025). Diagnostic accuracy of the TrueNat\u2122 MTB plus assay for detecting pulmonary tuberculosis in adults. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0327936"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.55489\/njcm.150320243413","article-title":"Diagnostic accuracy of the TrueNat MTB\/RIF assay and comparison with the reference standards to detect pulmonary tuberculosis and rifampicin resistance in sputum samples from patients attending a tertiary care hospital in Bhubaneswar, India","volume":"15","author":"Barik","year":"2024","journal-title":"Natl. J. Community Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"100420","DOI":"10.1016\/j.jctube.2024.100420","article-title":"Assessing the utility of Truenat in extrapulmonary tuberculosis diagnosis\u2014A NRL\u2019s experience","volume":"35","author":"Rajendran","year":"2024","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"ref_48","unstructured":"Ministry of Health and Family Welfare (MoHFW), Government of India (2025, December 20). India TB Report 2023, Available online: https:\/\/tbcindia.mohfw.gov.in\/wp-content\/uploads\/2023\/05\/5646719104TB_AR_2023_04-04-2023_LRP_final.pdf."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Raizada, N., Sachdeva, K.S., Sreenivas, A., Vadera, B., Gupta, R.S., Parmar, M., Kulsange, S., Babre, A., Thakur, R., and Gray, C. (2014). Feasibility of decentralised deployment of Xpert MTB\/RIF test at lower level of health system in India. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089301"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/ijcm.ijcm_471_22","article-title":"Cost-effectiveness of currently available diagnostic tools for diagnosis of pediatric tuberculosis under National Tuberculosis Elimination Program","volume":"48","author":"Bhatia","year":"2023","journal-title":"Indian J. Community Med."},{"key":"ref_51","unstructured":"Stop TB Partnership, and Global Drug Facility (GDF) (2024). GDF Product Catalog, Stop TB Partnership. Available online: https:\/\/www.stoptb.org\/what-we-do\/facilitate-access-tb-drugs-diagnostics\/global-drug-facility-gdf\/products-catalog."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.1093\/nar\/28.12.e63","article-title":"Loop-Mediated Isothermal Amplification of DNA","volume":"28","author":"Notomi","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_53","unstructured":"Eiken Chemical Co., Ltd. (2026). LAMP Operation, Eiken Chemical Co., Ltd.. Available online: https:\/\/www.eiken.co.jp\/en\/ourfields\/infection\/lamp_operation\/."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nprot.2008.57","article-title":"Loop-mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products","volume":"3","author":"Tomita","year":"2008","journal-title":"Nat. Protoc."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2144\/000114253","article-title":"Visual detection of isothermal nucleic acid amplification using pH-sensitive dyes","volume":"58","author":"Tanner","year":"2015","journal-title":"BioTechniques"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijid.2018.01.005","article-title":"Performance of the TB-LAMP diagnostic assay in reference laboratories: Results from a multicentre study","volume":"68","author":"Pham","year":"2018","journal-title":"Int. J. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.5588\/ijtld.10.0629","article-title":"Evaluation of a simple loop-mediated isothermal amplification test kit for the diagnosis of tuberculosis","volume":"15","author":"Mitarai","year":"2011","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Shete, P.B., Farr, K., Strnad, L., Gray, C.M., and Cattamanchi, A. (2019). Diagnostic accuracy of TB-LAMP for pulmonary tuberculosis: A systematic review and meta-analysis. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-3881-y"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/JCM.02352-06","article-title":"Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries","volume":"45","author":"Boehme","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.5588\/ijtld.17.0035","article-title":"Evaluation of the TB-LAMP assay for the rapid diagnosis of pulmonary tuberculosis in Northern India","volume":"21","author":"Yadav","year":"2017","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_61","first-page":"1792","article-title":"Tuberculosis-loop-mediated isothermal amplification implementation in Cameroon: Challenges, lessons learned and recommendations","volume":"11","author":"Ongoulal","year":"2022","journal-title":"Afr. J. Lab. Med."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Njiru, Z.K. (2012). Loop-mediated isothermal amplification technology: Towards point of care diagnostics. PLoS Neglected Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001572"},{"key":"ref_63","unstructured":"Abbott Molecular (2026). Infectious Disease Products: Molecular Testing for Each Step of the Infectious Disease Patient Journey, Abbott Molecular. Available online: https:\/\/www.molecular.abbott\/int\/en\/offerings\/products\/infectious-disease."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Scott, L.E., McCarthy, K., Gous, N., Nduna, M., Van Rie, A., Sanne, I., Venter, W.F., Duse, A., and Stevens, W. (2011). Comparison of Xpert MTB\/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: A prospective study. PLoS Med., 8.","DOI":"10.1371\/journal.pmed.1001061"},{"key":"ref_65","unstructured":"World Health Organization (2017). WHO Meeting Report: High-Priority Target Product Profiles for New Tuberculosis Diagnostics, WHO. Available online: https:\/\/www.who.int\/publications\/i\/item\/WHO-HTM-TB-2014.18."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s10096-024-04880-1","article-title":"Abbott RealTime MTB Assay for Detecting Mycobacterium tuberculosis Complex in Respiratory Specimens: A Cost-Benefit Analysis","volume":"43","author":"Ferrer","year":"2024","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/JB.00009-08","article-title":"IS6110, a Mycobacterium tuberculosis complex-specific insertion sequence, is also present in the genome of Mycobacterium smegmatis, suggestive of lateral gene transfer among mycobacterial species","volume":"190","author":"Coros","year":"2008","journal-title":"J. Bacteriol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tube.2017.03.002","article-title":"Clinical evaluation of the Abbott RealTime MTB Assay for direct detection of Mycobacterium tuberculosis-complex from respiratory and non-respiratory samples","volume":"104","author":"Feuz","year":"2017","journal-title":"Tuberculosis"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Araya, B.T., Ali, K.E., Geleta, D.A., Tekele, S.G., and Tulu, K.D. (2021). Performance of the Abbott RealTime MTB and RIF\/INH resistance assays for the detection of Mycobacterium tuberculosis and resistance markers in sputum specimens. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0251602"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/JCM.00553-13","article-title":"Rifampin drug resistance tests for tuberculosis: Challenging the gold standard","volume":"51","author":"Aung","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1128\/JCM.00289-17","article-title":"Performance of the Abbott RealTime MTB and MTB RIF\/INH assays in a setting of high tuberculosis and HIV coinfection in South Africa","volume":"55","author":"Scott","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.eimc.2019.08.007","article-title":"Field performance of the Abbott RealTime MTB assay for the diagnosis of extrapulmonary tuberculosis in a low-prevalence setting","volume":"38","author":"Vinuesa","year":"2020","journal-title":"Enfermedades Infecc. Microbiol. Cl\u00edn."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2147\/IDR.S147272","article-title":"Evaluation of a New Automated Abbott RealTime MTB RIF\/INH Assay for Qualitative Detection of Rifampicin\/Isoniazid Resistance in Pulmonary and Extra-Pulmonary Clinical Samples of Mycobacterium tuberculosis","volume":"10","author":"Ruiz","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"19271","DOI":"10.1038\/s41598-021-96922-3","article-title":"Diagnostic performance of the Abbott RealTime MTB assay for tuberculosis diagnosis in people living with HIV","volume":"11","author":"Saavedra","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Zeh, C., Ndiege, K., Inzaule, S., Achieng, R., Williamson, J., Chang, J.C.-W., Ellenberger, D., and Nkengasong, J. (2017). Evaluation of the performance of Abbott m2000 and Roche COBAS Ampliprep\/COBAS TaqMan assays for HIV-1 viral load determination using dried blood spots and dried plasma spots in Kenya. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179316"},{"key":"ref_76","unstructured":"Stop TB Partnership (2021). Practical Considerations for Implementation of the Abbott RealTime MTB and Abbott RealTime MTB RIF\/INH Tests, Stop TB Partnership. Available online: www.stoptb.org\/sites\/default\/files\/imported\/document\/Annex_2.1_Information_Sheet_-_Realtime_MTB_and_MTB_RIF-INH.pdf."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s10096-015-2419-5","article-title":"Performance of the New Automated Abbott RealTime MTB Assay for Rapid Detection of Mycobacterium tuberculosis Complex in Respiratory Specimens","volume":"34","author":"Chen","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.diagmicrobio.2015.11.001","article-title":"Performance characteristics of the new Abbott RealTime MTB assay for detection of Mycobacterium tuberculosis complex in respiratory specimens","volume":"84","author":"Vinuesa","year":"2016","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_79","unstructured":"Becton, Dickinson and Company (2026). BD MAX\u2122 System, Becton, Dickinson and Company. Available online: https:\/\/www.bd.com\/en-us\/products-and-solutions\/products\/product-families\/bd-max-system."},{"key":"ref_80","unstructured":"World Health Organization (2023). WHO Operational Handbook on Tuberculosis, Module 3: Diagnosis, World Health Organization. [3rd ed.]. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240089501."},{"key":"ref_81","unstructured":"Becton, Dickinson and Company (2026, January 04). BD MAX\u2122 MDR-TB Assay Performance. Available online: https:\/\/emea.bd.com\/advancing-diagnostics\/assays\/respiratory-infections\/bd-max-mdr-tb\/."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmi.2016.10.022","article-title":"Mycobacterium tuberculosis Drug-Resistance Testing: Challenges, Recent Developments and Perspectives","volume":"23","author":"Miotto","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e00912-25","DOI":"10.1128\/jcm.00912-25","article-title":"Off-Label Evaluation of the BD MAX MDR-TB Assay for Rapid Diagnosis of Rifampicin and Isoniazid Resistance of Mycobacterium tuberculosis Clinical Isolates in a High-Volume Reference Laboratory","volume":"63","author":"Brandao","year":"2025","journal-title":"J. Clin. Microbiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e02168-20","DOI":"10.1128\/JCM.02168-20","article-title":"Comparative Analytical Evaluation of Four Centralized Platforms for the Detection of Mycobacterium tuberculosis Complex and Resistance to Rifampicin and Isoniazid","volume":"59","author":"Scott","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"113","DOI":"10.12701\/jyms.2024.00024","article-title":"Performance of the BD MAX MDR-TB Assay in a Clinical Setting and Its Impact on the Clinical Course of Patients with Pulmonary Tuberculosis: A Retrospective Before-After Study","volume":"41","author":"Ko","year":"2024","journal-title":"J. Yeungnam Med. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4046\/trd.2024.0091","article-title":"Diagnostic Accuracy of BD MAX MDR-TB Assay Performed on Bronchoscopy Specimens in Patients with Suspected Pulmonary Tuberculosis","volume":"88","author":"Ko","year":"2025","journal-title":"Tuberc. Respir. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/cid\/cix169","article-title":"Mycobacterium tuberculosis Whole Genome Sequences From Southern India Suggest Novel Resistance Mechanisms and the Need for Region-Specific Diagnostics","volume":"64","author":"Manson","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41479-018-0049-2","article-title":"Rapid Molecular Assays for Detection of Tuberculosis","volume":"10","author":"Eddabra","year":"2018","journal-title":"Pneumonia"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Schumacher, S.G., Sohn, H., Qin, Z.Z., Gore, G., Davis, J.L., Denkinger, C.M., and Pai, M. (2016). Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study Methodologies. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151073"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s10096-020-03847-2","article-title":"Evaluation of the BD MAX\u2122 MDR-TB Assay in a Real-World Setting for the Diagnosis of Pulmonary and Extra-Pulmonary TB","volume":"39","author":"Ciesielczuk","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e00779-19","DOI":"10.1128\/JCM.00779-19","article-title":"Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB\/RIF Assays","volume":"57","author":"Murray","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"ref_92","unstructured":"Hain Lifescience (2023). GenoType\u00ae MTBDRplus and MTBDRsl Package Inserts, Hain Lifescience. Available online: https:\/\/www.hain-lifescience.de\/en\/products\/microbiology\/mycobacteria\/."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Hofmann-Thiel, S., and Hoffmann, H. (2014). Evaluation of FluoroType MTB for Detection of Mycobacterium tuberculosis Complex DNA in Clinical Specimens from a Low-Incidence Country. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-59"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"00113-2016","DOI":"10.1183\/23120541.00113-2016","article-title":"FluoroType MTB System for the Detection of Pulmonary Tuberculosis","volume":"3","author":"Obasanya","year":"2017","journal-title":"ERJ Open Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e01054-23","DOI":"10.1128\/jcm.01054-23","article-title":"Evaluation of the FluoroType Mycobacteria Assay for Identification of Mycobacteria","volume":"62","author":"Luukinen","year":"2024","journal-title":"J. Clin. Microbiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/13102818.2018.1466662","article-title":"Evaluation of FluoroType MTB for direct detection of Mycobacterium tuberculosis complex and GenoType MTBDRplus for determining rifampicin and isoniazid resistance","volume":"32","author":"Satana","year":"2018","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"ref_97","first-page":"e1","article-title":"Diagnostic Performance of the FluoroType MTBDR Assay for Rifampicin and Isoniazid Resistance in Routine Laboratory Setting","volume":"18","author":"Rukasha","year":"2026","journal-title":"Afr. J. Prim. Health Care Fam. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmi.2016.09.008","article-title":"Whole Genome Sequencing of Mycobacterium tuberculosis for Detection of Drug Resistance: A Systematic Review","volume":"23","author":"Papaventsis","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_99","unstructured":"World Health Organization (2021). WHO Consolidated Guidelines on Tuberculosis. Module 3: Diagnosis\u2014Rapid Diagnostics for Tuberculosis Detection, 2021 Update, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240029415."},{"key":"ref_100","unstructured":"Roche Diagnostics (2025). cobas\u00ae MTB-RIF\/INH for Use on the cobas\u00ae 5800\/6800\/8800 Systems, Roche Diagnostics. Available online: https:\/\/diagnostics.roche.com\/global\/en\/products\/lab\/cobas-mtb-rif-inh-58-68-88-pid00000332.html."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"107605","DOI":"10.1016\/j.ijantimicag.2025.107605","article-title":"Evaluation of the Roche cobas MTB and MTB-RIF\/INH for Detecting Mycobacterium tuberculosis Complex and Resistance to Isoniazid and Rifampicin: A Prospective, Multicenter Diagnostic Accuracy Study","volume":"66","author":"Hsueh","year":"2025","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_102","unstructured":"Roche Diagnostics (2025). Roche Announces U.S. Launch of Next Generation cobas\u00ae 6800\/8800 Systems and Software, Enhancing Laboratory Efficiency and Testing Capabilities, Roche Diagnostics. Available online: https:\/\/diagnostics.roche.com\/us\/en\/news-listing\/2025\/next-generation-cobas-6800-8800.html."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1080\/14737159.2019.1665999","article-title":"Generating Timely Molecular Diagnostic Test Results: Workflow Comparison of the cobas\u00ae 6800\/8800 to Panther","volume":"19","author":"Aretzweiler","year":"2019","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e02983-20","DOI":"10.1128\/JCM.02983-20","article-title":"Evaluation of the Roche cobas MTB and MTB-RIF\/INH assays in samples from Germany and Sierra Leone","volume":"59","author":"Nadarajan","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"102199","DOI":"10.1016\/j.tube.2022.102199","article-title":"Clinical evaluation of the cobas\u00ae MTB-RIF\/INH reagent and the cobas\u00ae 6800 for the detection of isoniazid and rifampicin resistance","volume":"134","author":"Aono","year":"2022","journal-title":"Tuberculosis"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jmoldx.2024.05.004","article-title":"Accuracy of cobas MTB and MTB-RIF\/INH for detection of Mycobacterium tuberculosis and drug resistance","volume":"26","author":"David","year":"2024","journal-title":"J. Mol. Diagn."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/thorax-2023-220202","article-title":"Challenging the gold standard: The limitations of molecular assays for detection of Mycobacterium tuberculosis heteroresistance","volume":"79","author":"Danchuk","year":"2024","journal-title":"Thorax"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e01959-24","DOI":"10.1128\/jcm.01959-24","article-title":"Evaluation of the cobas MTB and MTB-RIF\/INH assay in clinical samples for the detection of Mycobacterium tuberculosis in respiratory specimens","volume":"63","author":"Eigner","year":"2025","journal-title":"J. Clin. Microbiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"103728","DOI":"10.1016\/j.eclinm.2025.103728","article-title":"Cost and Impact of Decentralized Tuberculosis Testing: A Modeling Analysis of Price Thresholds for Molecular Instruments in High-Burden Settings","volume":"91","author":"Ockhuisen","year":"2026","journal-title":"EClinicalMedicine"},{"key":"ref_110","unstructured":"Roche Diagnostics (2025, August 20). cobas\u00ae MTB; Roche Diagnostics: Rotkreuz, Switzerland. Available online: https:\/\/diagnostics.roche.com\/global\/en\/products\/lab\/cobas-mtb-58-68-88-pid00000333.html."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"100410","DOI":"10.1016\/j.jctube.2023.100410","article-title":"Discordance between genotypic and phenotypic methods for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis and the correlation with patient treatment outcomes","volume":"34","author":"Bonsa","year":"2023","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"ref_112","unstructured":"Cepheid (2021). Xpert\u00ae MTB\/XDR Package Insert, Cepheid. Available online: https:\/\/web-support.cepheid.com\/en_US\/package-inserts."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1473-3099(21)00452-7","article-title":"Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB\/XDR assay: A cross-sectional multicentre diagnostic accuracy study","volume":"22","author":"Georghiou","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"8659735","DOI":"10.1155\/ijm\/8659735","article-title":"Evaluation of Xpert MTB\/XDR and Deeplex Myc-TB for the rapid detection of drug resistance in Mycobacterium tuberculosis","volume":"2026","author":"Park","year":"2026","journal-title":"Int. J. Microbiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"100520","DOI":"10.1016\/j.jctube.2025.100520","article-title":"Detection of extensive drug resistance by the Xpert MTB\/XDR assay in multidrug resistant tuberculosis cases at a tertiary care centre in northern India, and therapeutic decision making for the six-month BPaLM regimen","volume":"39","author":"Misra","year":"2025","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Keller, S., Naidoo, K., Zekarias, M., Israel-Isah, S., Shaka, M., Gule, G., Naidoo, A., Bathnna, M., Dlamini-Miti, J.N., and Yae, K. (2025). Feasibility and acceptability of GeneXpert MTB\/XDR implementation among healthcare workers in three low-middle income African countries. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0326342"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e710","DOI":"10.1016\/S2214-109X(17)30205-X","article-title":"Cost-effectiveness of Xpert MTB\/RIF for tuberculosis diagnosis in South Africa: A real-world cost analysis and economic evaluation","volume":"5","author":"Vassall","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"ofaf695.1856","DOI":"10.1093\/ofid\/ofaf695.1856","article-title":"P-1682. Accuracy of Xpert MTB\/XDR Panel to detect antitubercular drug resistance in Indian children","volume":"13","author":"Gandhi","year":"2026","journal-title":"Open Forum Infect. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"00427","DOI":"10.1183\/23120541.00427-2025","article-title":"Multicentre Field Evaluation of Xpert MTB\/XDR in Sub-Saharan Africa","volume":"12","author":"Massou","year":"2026","journal-title":"ERJ Open Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1183\/09031936.00061808","article-title":"GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: A meta-analysis","volume":"32","author":"Ling","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1164\/rccm.200709-1436OC","article-title":"Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South Africa","volume":"177","author":"Barnard","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JCM.01865-16","article-title":"Evaluation of the GenoType MTBDRsl Version 2.0 assay for second-line drug resistance detection of Mycobacterium tuberculosis isolates in South Africa","volume":"55","author":"Gardee","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1378\/chest.14-1286","article-title":"Drug resistance in Mycobacterium tuberculosis: Molecular mechanisms challenging fluoroquinolones and pyrazinamide effectiveness","volume":"147","author":"Miotto","year":"2015","journal-title":"Chest"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1128\/JCM.00201-10","article-title":"Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis","volume":"48","author":"Kiet","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Albert, H., Bwanga, F., Mukkada, S., Nyesiga, B., Ademun, J.P., Lukyamuzi, G., Haile, M., Hoffner, S., Joloba, M., and O\u2019Brien, R. (2010). Rapid Screening of MDR-TB Using Molecular Line Probe Assay Is Feasible in Uganda. BMC Infect. Dis., 10.","DOI":"10.1186\/1471-2334-10-41"},{"key":"ref_126","unstructured":"Nipro Corporation (2026). GENOSCHOLAR\u2122 NTM+MDRTB II Line Probe Assay, Nipro Corporation. Available online: https:\/\/www.environmental-expert.com\/products\/nipro-model-genoscholar-ntm-mdrtb-ii-line-probe-assay-834330."},{"key":"ref_127","unstructured":"Nipro Corporation (2025). GENOSCHOLAR\u2122 PZA-TB II, Nipro Corporation. Available online: https:\/\/niproasia.com.sg\/product\/genoscholartm-pza-tb-ii\/."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Yadav, R.N., Singh, B.K., Sharma, S.K., Sharma, R., Soneja, M., Sreenivas, V., Myneedu, V.P., Hanif, M., Kumar, A., and Sachdeva, K.S. (2013). Comparative Evaluation of GenoType MTBDRplus Line Probe Assay with Solid Culture Method in Early Diagnosis of Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Centre in India. PLoS ONE, 8.","DOI":"10.1371\/annotation\/e90efdb7-91c1-45f0-ae98-a88fcb407acc"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1128\/JCM.00251-16","article-title":"Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance","volume":"54","author":"Nathavitharana","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_130","unstructured":"Stop TB Partnership (2025, December 20). Information Sheets, Available online: https:\/\/www.stoptb.org\/information-sheets."},{"key":"ref_131","unstructured":"Stop TB Partnership, and Global Drug Facility (GDF) (2024). Diagnostics, Medical Devices & Other Health Products Catalog, Stop TB Partnership. Available online: https:\/\/www.stoptb.org\/sites\/default\/files\/documents\/2024.10.30_gdf_diagnostics_md_catalog.pdf."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1701354","DOI":"10.1183\/13993003.01354-2017","article-title":"A Standardised Method for Interpreting the Association between Mutations and Phenotypic Drug Resistance in Mycobacterium tuberculosis","volume":"50","author":"Miotto","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_133","unstructured":"(2025, December 20). Deeplex\u00ae Myc-TB\u2014Un Nouveau Test de Pr\u00e9diction des R\u00e9sistances aux Antibiotiques de Mycobacterium tuberculosis: GenoScreen. Available online: https:\/\/www.genoscreen.fr\/fr\/services-genomiques\/produits\/deeplex-myc-tb-test-antibioresistance."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/JCM.02483-16","article-title":"Same-Day Diagnostic and Surveillance Data for Tuberculosis via Whole-Genome Sequencing of Direct Respiratory Samples","volume":"55","author":"Votintseva","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41579-019-0214-5","article-title":"Whole Genome Sequencing of Mycobacterium tuberculosis: Current Standards and Open Issues","volume":"17","author":"Meehan","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e00632-20","DOI":"10.1128\/JCM.00632-20","article-title":"Application of Targeted Next-Generation Sequencing Assay on a Portable Sequencing Platform for Culture-Free Detection of Drug-Resistant Tuberculosis from Clinical Samples","volume":"58","author":"Cabibbe","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2002338","DOI":"10.1183\/13993003.02338-2020","article-title":"Deep Amplicon Sequencing for Culture-Free Prediction of Susceptibility or Resistance to 13 Anti-Tuberculous Drugs","volume":"57","author":"Jouet","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_138","unstructured":"(2025, December 20). New Evidence Supports Deeplex\u00ae Myc-TB as the Reference Method for Enhanced Drug-Resistant TB Detection. GenoScreen. Available online: https:\/\/www.deeplex.com\/news\/new-evidence-supports-deeplex-myc-tb."},{"key":"ref_139","unstructured":"Oxford Nanopore Diagnostics (2025). AmPORE-TB Product Documentation, Oxford Nanopore Diagnostics. Available online: https:\/\/nanoporetech.com\/ond\/documentation\/ampore-tb."},{"key":"ref_140","unstructured":"Oxford Nanopore Technologies (2026). Library Preparation, Oxford Nanopore Technologies. Available online: https:\/\/nanoporetech.com\/products\/prepare."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e00666-18","DOI":"10.1128\/JCM.00666-18","article-title":"Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing","volume":"56","author":"Doyle","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1016\/S2666-5247(21)00301-3","article-title":"The 2021 WHO Catalogue of Mycobacterium tuberculosis Complex Mutations Associated with Drug Resistance: A Genotypic Analysis","volume":"3","author":"Walker","year":"2022","journal-title":"Lancet Microbe"},{"key":"ref_143","unstructured":"Oxford Nanopore Technologies (2025). GridION Q User Manual (Q_GRD_revC_06Jan2025) [Internet], Oxford Nanopore Technologies. Available online: https:\/\/nanoporetech.com\/document\/gridion-q-user-manual."},{"key":"ref_144","unstructured":"Hangzhou Shengting Medical Technology Co., Ltd. (2026). TBseq\u00ae Test: Targeted Sequencing Assay for Tuberculosis Diagnosis and Drug Resistance Detection [Internet], Hangzhou Shengting Medical Technology Co., Ltd.. Available online: https:\/\/www.shengtinggroup.com."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e019135","DOI":"10.1136\/bmjgh-2025-019135","article-title":"Targeted Next-Generation Sequencing for Drug-Resistant Tuberculosis Diagnosis: Implementation Considerations for Bacterial Load, Regimen Selection and Diagnostic Algorithm Placement","volume":"10","author":"Georghiou","year":"2025","journal-title":"BMJ Glob. Health"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Ou, X., Pei, S., Li, H., Qin, Z., Anthony, R., Wang, J., Song, Z., Xing, R., Zhang, L., and Teng, C. (2025). A Comprehensive Evaluation of a Novel Targeted-Sequencing Workflow for Mycobacterium Species Identification and Anti-Tuberculosis Drug-Resistance Detection. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1584237"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"de Araujo, L., Cabibbe, A.M., Mhuulu, L., Ruswa, N., Dreyer, V., Diergaardt, A., G\u00fcnther, G., Claassens, M., Gerlach, C., and Utpatel, C. (2023). Implementation of Targeted Next-Generation Sequencing for the Diagnosis of Drug-Resistant Tuberculosis in Low-Resource Settings: A Programmatic Model, Challenges, and Initial Outcomes. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1204064"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Creswell, J., Codlin, A.J., Andre, E., Micek, M.A., Bedru, A., Carter, E.J., Yadav, R.P., Mosneaga, A., Rai, B., and Banu, S. (2014). Results from Early Programmatic Implementation of Xpert MTB\/RIF Testing in Nine Countries. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-2"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1183\/09031936.00157212","article-title":"Rapid Molecular TB Diagnosis: Evidence, Policy Making and Global Implementation of Xpert MTB\/RIF","volume":"42","author":"Weyer","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"ofw068","DOI":"10.1093\/ofid\/ofw068","article-title":"Implementation of Xpert MTB\/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis","volume":"3","author":"Hanrahan","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0140-6736(13)62073-5","article-title":"Feasibility, Accuracy, and Clinical Effect of Point-of-Care Xpert MTB\/RIF Testing for Tuberculosis in Primary-Care Settings in Africa: A Multicentre, Randomised, Controlled Trial","volume":"383","author":"Theron","year":"2014","journal-title":"Lancet"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/ETLS20200335","article-title":"Tuberculosis Diagnostics: Overcoming Ancient Challenges with Modern Solutions","volume":"4","author":"Wilkinson","year":"2020","journal-title":"Emerg. Top. Life Sci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41564-019-0380-2","article-title":"A Systematic Review of Biomarkers to Detect Active Tuberculosis","volume":"4","author":"MacLean","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Escombe, A.R., Oeser, C.C., Gilman, R.H., Navincopa, M., Ticona, E., Pan, W., Mart\u00ednez, C., Chacaltana, J., Rodr\u00edguez, R., and Moore, D.A.J. (2007). Natural Ventilation for the Prevention of Airborne Contagion. PLoS Med., 4.","DOI":"10.1371\/journal.pmed.0040068"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10096-024-05032-1","article-title":"Diagnostic Accuracy of Xpert MTB\/RIF Ultra for Detecting Pulmonary Tuberculosis and Rifampicin Resistance: A Systematic Review and Meta-Analysis","volume":"44","author":"Wang","year":"2025","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Menzies, N.A., Cohen, T., Lin, H.H., Murray, M., and Salomon, J.A. (2012). Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB\/RIF: A Dynamic Simulation and Economic Evaluation. PLoS Med., 9.","DOI":"10.1371\/journal.pmed.1001347"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"723","DOI":"10.5588\/ijtld.17.0835","article-title":"Global Tuberculosis Targets and Milestones Set for 2016\u20132035: Definition and Rationale","volume":"22","author":"Floyd","year":"2018","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2471\/BLT.11.101436","article-title":"The Impact of New Tuberculosis Diagnostics on Transmission: Why Context Matters","volume":"90","author":"Lin","year":"2012","journal-title":"Bull. World Health Organ."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Gunasekera, K.S., Vonasek, B., Oliwa, J., Triasih, R., Lancioni, C., Graham, S.M., Seddon, J.A., and Marais, B.J. (2022). Diagnostic Challenges in Childhood Pulmonary Tuberculosis\u2014Optimizing the Clinical Approach. Pathogens, 11.","DOI":"10.3390\/pathogens11040382"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0140-6736(05)17702-2","article-title":"Induced Sputum versus Gastric Lavage for Microbiological Confirmation of Pulmonary Tuberculosis in Infants and Young Children: A Prospective Study","volume":"365","author":"Zar","year":"2005","journal-title":"Lancet"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijid.2021.11.012","article-title":"Use of Xpert MTB\/RIF Ultra Assay on Stool and Gastric Aspirate Samples to Diagnose Pulmonary Tuberculosis in Children in a High-Tuberculosis-Burden but Resource-Limited Area of China","volume":"114","author":"Sun","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"e02057-18","DOI":"10.1128\/JCM.02057-18","article-title":"Diagnostic Accuracy of Stool Xpert MTB\/RIF for Detection of Pulmonary Tuberculosis in Children: A Systematic Review and Meta-analysis","volume":"57","author":"MacLean","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cid\/ciaa583","article-title":"Xpert Ultra Assay on Stool to Diagnose Pulmonary Tuberculosis in Children","volume":"73","author":"Kabir","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_164","unstructured":"World Health Organization (2019). Lateral Flow Urine Lipoarabinomannan Assay (LF-LAM) for the Diagnosis of Active Tuberculosis in People Living with HIV: 2019 Update, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789241550604."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Taye, B., Tesfaye, H., and Churiso, G. (2025). FujiLAM Assays for Tuberculosis Detection in People with HIV: A Systematic Review and Meta-Analysis. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-12055-2"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Broger, T., Nicol, M.P., Sz\u00e9kely, R., Bjerrum, S., Sossen, B., Schutz, C., Opintan, J.A., Johansen, I.S., Mitarai, S., and Chikamatsu, K. (2020). Diagnostic Accuracy of a Novel Tuberculosis Point-of-Care Urine Lipoarabinomannan Assay for People Living with HIV: A Meta-Analysis of Individual In- and Outpatient Data. PLoS Med., 17.","DOI":"10.1371\/journal.pmed.1003113"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"e183779","DOI":"10.1001\/jamanetworkopen.2018.3779","article-title":"Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response","volume":"1","author":"Warsinske","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Darboe, F., Mbandi, S.K., Naidoo, K., Yende-Zuma, N., Lewis, L., Thompson, E.G., Duffy, F.J., Fisher, M., Filander, E., and van Rooyen, M. (2019). Detection of tuberculosis recurrence, diagnosis and treatment response by a blood transcriptomic risk signature in HIV-infected persons on antiretroviral therapy. Front Microbiol., 10.","DOI":"10.3389\/fmicb.2019.01441"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"8668","DOI":"10.1038\/srep08668","article-title":"Detection of Mycobacterium tuberculosis DNA on the oral mucosa of tuberculosis patients","volume":"5","author":"Wood","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/cid\/ciac332","article-title":"Oral Swab Specimens Tested with Xpert MTB\/RIF Ultra Assay for Diagnosis of Pulmonary Tuberculosis in Children: A Diagnostic Accuracy Study","volume":"75","author":"Cox","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5588\/ijtldopen.24.0334","article-title":"Stool Xpert\u00ae MTB\/RIF Ultra for TB Diagnosis in Children: Experience from a National Scale-Up Programme","volume":"1","author":"Kabir","year":"2024","journal-title":"IJTLD Open"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aar6245","article-title":"CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity","volume":"360","author":"Chen","year":"2018","journal-title":"Science"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.aam9321","article-title":"Nucleic Acid Detection with CRISPR-Cas13a\/C2c2","volume":"356","author":"Gootenberg","year":"2017","journal-title":"Science"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1080\/22221751.2019.1664939","article-title":"CRISPR-Based Rapid and Ultra-Sensitive Diagnostic Test for Mycobacterium tuberculosis","volume":"8","author":"Ai","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.tibtech.2018.12.005","article-title":"CRISPR\/Cas Systems towards Next-Generation Biosensing","volume":"37","author":"Li","year":"2019","journal-title":"Trends Biotechnol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1038\/s41467-020-18615-1","article-title":"Enhancement of Trans-Cleavage Activity of Cas12a with Engineered crRNA Enables Amplified Nucleic Acid Detection","volume":"11","author":"Nguyen","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cell.2016.04.059","article-title":"Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components","volume":"165","author":"Pardee","year":"2016","journal-title":"Cell"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/13\/2133\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:16:16Z","timestamp":1783656976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/13\/2133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":177,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["diagnostics16132133"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16132133","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}